Table 1 Baseline clinical characteristics
Variables | EAT ≥ 3.5 mm | EAT < 3.5 mm | P value |
|---|---|---|---|
(n = 350) | (n = 411) | ||
Age (year-old) | 61 ± 12 | 54 ± 12 | <0.001 |
Men, n (%) | 253 (72) | 361 (88) | <0.001 |
BMI (kg/m2) | 24 ± 3 | 25 ± 3 | 0.331 |
Medical History | |||
Hypertension, n (%) | 157 (45) | 140 (34) | 0.002 |
Diabetes Mellitus, n (%) | 81 (23) | 77 (19) | 0.138 |
Dyslipidemia, n (%) | 25 (7) | 32 (8) | 0.737 |
Previous CVA, n (%) | 11 (3) | 12 (3) | 0.858 |
Smoking, n (%) | 206 (59) | 285 (69) | 0.003 |
LDL cholesterol (mg/dl ) | 106 ± 32 | 102 ± 34 | 0.079 |
hs-CRP (mg/L) | 1.3 ± 3 | 1.1 ± 3 | 0.46 |
Killip class | |||
Killip class 3, n (%) | 26 (7) | 27 (7) | 0.643 |
Killip class 4, n (%) | 12 (3) | 16 (4) | 0.734 |
Medication at discharge | |||
Beta-blocker, n (%) | 234 (67) | 292 (71) | 0.214 |
ACE inhibitor, n (%) | 230 (66) | 257 (63) | 0.362 |
ARB, n (%) | 110 (31) | 135 (33) | 0.677 |
CCB, n (%) | 61 (17) | 64 (16) | 0.491 |
statin, n (%) | 245 (70) | 277 (67) | 0.441 |